ATE541861T1 - Verwendung eines antikörpers gegen cd151 zur frühen behandlung von krebs - Google Patents
Verwendung eines antikörpers gegen cd151 zur frühen behandlung von krebsInfo
- Publication number
- ATE541861T1 ATE541861T1 AT09742229T AT09742229T ATE541861T1 AT E541861 T1 ATE541861 T1 AT E541861T1 AT 09742229 T AT09742229 T AT 09742229T AT 09742229 T AT09742229 T AT 09742229T AT E541861 T1 ATE541861 T1 AT E541861T1
- Authority
- AT
- Austria
- Prior art keywords
- antibody
- cancer
- early treatment
- protein
- binding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0801865A FR2929519B1 (fr) | 2008-04-04 | 2008-04-04 | Utilisation d'un anticorps anti-cd151 pour le traitement precoce des cancers. |
PCT/FR2009/050561 WO2009136031A1 (fr) | 2008-04-04 | 2009-04-02 | Utilisation d'un anticorps anti-cd151 pour le traitement precoce des cancers |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE541861T1 true ATE541861T1 (de) | 2012-02-15 |
Family
ID=40100352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT09742229T ATE541861T1 (de) | 2008-04-04 | 2009-04-02 | Verwendung eines antikörpers gegen cd151 zur frühen behandlung von krebs |
Country Status (7)
Country | Link |
---|---|
US (1) | US20110165062A1 (de) |
EP (1) | EP2262839B1 (de) |
JP (1) | JP2011516458A (de) |
AT (1) | ATE541861T1 (de) |
ES (1) | ES2380892T3 (de) |
FR (1) | FR2929519B1 (de) |
WO (1) | WO2009136031A1 (de) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6245898B1 (en) * | 1998-06-15 | 2001-06-12 | The Research Foundation Of State University Of New York | Monoclonal antibodies that recognize antigens associated with tumor metastasis |
FR2929946B1 (fr) * | 2008-04-11 | 2010-05-28 | Pf Medicament | Nouveaux anticorps anti-cd151 et leur utilisation pour le traitement du cancer |
-
2008
- 2008-04-04 FR FR0801865A patent/FR2929519B1/fr not_active Expired - Fee Related
-
2009
- 2009-04-02 US US12/736,358 patent/US20110165062A1/en not_active Abandoned
- 2009-04-02 WO PCT/FR2009/050561 patent/WO2009136031A1/fr active Application Filing
- 2009-04-02 AT AT09742229T patent/ATE541861T1/de active
- 2009-04-02 ES ES09742229T patent/ES2380892T3/es active Active
- 2009-04-02 JP JP2011502423A patent/JP2011516458A/ja active Pending
- 2009-04-02 EP EP09742229A patent/EP2262839B1/de not_active Not-in-force
Also Published As
Publication number | Publication date |
---|---|
EP2262839A1 (de) | 2010-12-22 |
ES2380892T3 (es) | 2012-05-21 |
JP2011516458A (ja) | 2011-05-26 |
FR2929519A1 (fr) | 2009-10-09 |
WO2009136031A1 (fr) | 2009-11-12 |
FR2929519B1 (fr) | 2010-04-23 |
EP2262839B1 (de) | 2012-01-18 |
US20110165062A1 (en) | 2011-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA94452C2 (ru) | Гуманизированные моноклональные антитела к фактору роста гепатоцитов | |
WO2010054265A3 (en) | Monoclonal antibodies to fibroblast growth factor receptor 2 | |
MX357972B (es) | Materiales y metodos para el tratamiento o prevencion de enfermedades asociadas al her-3. | |
UA109633C2 (uk) | Антитіло людини проти тканинного фактора | |
WO2014012007A3 (en) | Rspo3 binding agents and uses thereof | |
CY1115572T1 (el) | Αντι cxcr4 αντισωματα και χρηση αυτων για τη θεραπεια καρκινου | |
WO2010005566A3 (en) | Notch-binding agents and antagonists and methods of use thereof | |
MX2014000555A (es) | Agentes que se unen a las proteinas de r-espondinas (rspo) y usos de los mismos. | |
MY149630A (en) | Antibodies against amyloid-beta peptide | |
TN2010000210A1 (en) | Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same | |
BR112012024713A2 (pt) | "anticorpo humanizado, anticorpo monoclonal humanizado ou fragmento de anticorpo, seus usos, polinucleotídeo isolado, e composição farmacêutica" | |
WO2008142303A3 (fr) | Utilisation d'un anticorps anti-cxcr4 pour le traitement du cancer | |
BRPI0813499B8 (pt) | compostos pirimidina carboxamidas úteis como inibidores da quinase raf, composição farmacêutica compreendendo os mesmos e método de preparação dos mesmos | |
EA201001639A1 (ru) | Композиции и способы их получения и применения | |
EA201170590A1 (ru) | Ингибиторы рецептора фактора роста фибробластов-3 (fgfr-3) и способы лечения | |
MX2010002716A (es) | Uso de slit, nefrina, efrina o semaforina para el tratamiento de enfermedades de cartilago. | |
CY1115349T1 (el) | Εξανθρωπισμενα αντι cxcr4 αντισωματα για τη θεραπεια καρκινου | |
MX2009003039A (es) | Utilizacion de un anticuerpo anti-cd151 para el tratamiento del cancer. | |
CA2725873A1 (en) | Monoclonal antibodies to basic fibroblast growth factor | |
WO2011063237A3 (en) | Jagged-binding agents and uses thereof | |
WO2010086828A3 (en) | Agonist anti-trkb monoclonal antibodies | |
NZ602515A (en) | Proteins that bind pi16 and uses thereof | |
EA201390117A1 (ru) | Композиция антител к vegfr-3 | |
ATE541861T1 (de) | Verwendung eines antikörpers gegen cd151 zur frühen behandlung von krebs | |
DE602005025459D1 (de) | Ephb4-bindende antikörper zur inhibierung von angiogenese und tumorwachstum |